Abbott in talks to buy exact sciences as cologuard makers shares jump

Abbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the possible deal is in advanced stages, and the news has pushed Exact Sciences stock higher. The talks are still ongoing, and nothing is final yet. The focus is on Abbott, Exact Sciences, and the cancer-test market.